Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics, Inc. (CVKD) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 40 transactions totaling $871.2K, demonstrating a bearish sentiment with -$548.4K in net insider flow. The most recent transaction on Dec 29, 2025 involved a sale of 9,933 shares valued at $69.2K.
CVKD Insider Activity Summary
Who Is Buying CVKD Stock?
No significant insider buying has been recorded for CVKD in the recent period.
Who Is Selling CVKD Stock?
No significant insider selling has been recorded for CVKD in the recent period.
Is Cadrenal Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CVKD is bearish with an Insider Alignment Score of 19/100 and a net flow of -$548.4K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
CVKD Frequently Asked Questions
Understanding CVKD Insider Activity
Insider trading at Cadrenal Therapeutics, Inc. (CVKD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading CVKD stock, having executed 40 transactions in the past 90 days. The most active insider is Quang X. Pham (Executive), who has made 21 transactions totaling $461.0K.
Related Tools
Track Cadrenal Therapeutics, Inc. Insider Activity
Get notified when executives and directors at CVKD file new Form 4 transactions